{
    "id": "correct_subsidiary_00045_3",
    "rank": 94,
    "data": {
        "url": "https://auau.auanet.org/content/management-prostate-cancer-case-based-approach-emphasis-integrating-new-molecular-7",
        "read_more_link": "",
        "language": "en",
        "title": "Management of Prostate Cancer: A Case-Based Approach with Emphasis on Integrating New Molecular Diagnostics into Clinical Practice Webcast 078IC (2018)",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://auau.auanet.org/sites/default/files/AUAUniversity_65.png",
            "https://auau.auanet.org/sites/all/themes/ce/css/images/facebook.png",
            "https://auau.auanet.org/sites/all/themes/ce/css/images/twitter.png",
            "https://auau.auanet.org/sites/all/themes/ce/css/images/linkedin.png",
            "https://auau.auanet.org/sites/all/themes/ce/css/images/forward.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://auau.auanet.org/sites/default/files/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://auau.auanet.org/content/management-prostate-cancer-case-based-approach-emphasis-integrating-new-molecular-7",
        "text": "Method of Participation\n\nTo claim CME credit/hours of participation, the learner must view the webcast, complete the post-test passing with 80% accuracy and submit the activity evaluation.\n\nEstimated time to complete this activity: 2.00 hour\n\nRelease Date: June, 2018\n\nExpiration Date: June, 2019\n\nAccreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nAMA Credit Designation: The American Urological Association designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\n\nOther Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1.00 Credit™.\n\nEvidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.\n\nAUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.\n\nResolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:\n\nPeer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.\n\nLimit content to evidence with no recommendations\n\nIntroduction of a debate format with an unbiased moderator (point-counterpoint)\n\nInclusion of moderated panel discussion\n\nPublication of a parallel or rebuttal article for an article that is felt to be biased\n\nLimit equipment representatives to providing logistics and operation support only in procedural demonstrations\n\nDivestiture of the relationship by faculty\n\nDisclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.\n\nAcknowledgements: Support provided by an independent education grant from AbbVie, Astellas, Genomic Health, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Medivation, Inc. a Pfizer company and Sanofi Genzyme."
    }
}